We are leaders in CRISPR/Cas9 gene targeting
. Our fees
are low, and our success rates
are high. New transgenic and targeted mice that we have created are featured in over 300 publications
. We are supported by the Case Western Reserve University School of Medicine
the Case Comprehensive Cancer Center
, the Clinical and Translational Science Collaborative
, the Research Institute for Children's Health
and by grants from the NIH, the Cystic Fibrosis Foundation and JobsOhio. We are a component of the FIND Pipeline
, which translates gene-directed approaches into therapies for inherited disease.
We are growing with two open positions
, one for an experienced microinjectionist, and one to perform cryopreservation.